Phuturdex › Diseases › Lower urinary tract symptoms
Drugs in development · updated 30 October 2026
Lower urinary tract symptoms: drugs in development
As of 30 October 2026 there are 3 active clinical trials (recruiting or ongoing, phases I–III) on 4 drugs for lower urinary tract symptoms. One is experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| MelatoninSlenyto®, Circadin® | II | 1 | NCT07617922 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| TadalafilChewtadzy®, Tadliq® | II–III | 1 | NCT05955001 |
| SolifenacinVesicare Ls®, Vesicare® | II | 1 | NCT07617922 |
| TamsulosinFlomax® | II | 1 | NCT05401032 |
Sorted by most advanced phase and number of active trials.
All 4 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Overactive bladder 9 drugs
- Urinary incontinence 6 drugs
- Spinal cord injury 25 drugs
- Nocturia 5 drugs
- Prostatic Neoplasms 383 drugs
- Erectile dysfunction 32 drugs
- Urologic Diseases 16 drugs
- Interstitial cystitis 10 drugs
Broader categories
- Urogenital Diseases 16 drugs
- Male urogenital disease 19 drugs
- Urologic Diseases 16 drugs
- Female urogenital disease 11 drugs
- Female urogenital diseases and pregnancy complications 3 drugs
- Genital Diseases 7 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D059411 “Lower Urinary Tract Symptoms”.